Werewolf Therapeutics (HOWL) Appoints Anil Singhal to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. LLY
4. META
5. ACCV
6. SPCX
7. MSFT
8. AZN
9. FLG
10. FICO

Go back to Werewolf Therapeutics (HOWL) Appoints Anil Singhal to its Board

Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors

February 24, 2025 7:30 AM EST

WATERTOWN, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the bodys immune system for the treatment of cancer and immunological diseases, today announced the appointment of Anil Singhal, Ph.D., President and Chief Executive Officer of Trishula Therapeutics, as a member of its board of directors.

I am thrilled to join Werewolfs board of directors as the company advances its novel INDUKINE molecules through clinical development, said Dr. Singhal. Werewolf is demonstrating... More